← FDA Drug Approvals (Drugs@FDA)

PROMACTA

NDA · New Drug Application · Sponsor: NOVARTIS · Approved 2008-11-20

Drug application

FDA Application #
NDA022291
Application type
New Drug Application
Brand name
PROMACTA
Generic name
ELTROMBOPAG OLAMINE
Active ingredients
ELTROMBOPAG OLAMINE
Dosage form
TABLET
Route
ORAL
Marketing status
Discontinued
Sponsor
NOVARTIS
Manufacturer
Novartis Pharmaceuticals Corporation
First approval
2008-11-20

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown